<DOC>
	<DOC>NCT00330083</DOC>
	<brief_summary>This trial is performed to assess whether ALK Ragweed Tablet is safe to use in adults</brief_summary>
	<brief_title>Safety of ALK Ragweed Tablet</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>Ragweed pollen induced rhinoconjunctivitis Adults of either sex (1850 years of age) Positive skin prick test to ragweed Previous treatment with immunotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>